國芳集團(601086.SH):擬出資1545萬元參設嘉興御道數科股權投資合夥企業
格隆匯8月1日丨國芳集團(601086.SH)公佈,公司擬與上海譽道創業投資管理有限公司(以下簡稱“譽道創投”)及其他合夥人共同簽署《嘉興御道數科股權投資合夥企業(有限合夥)合夥協議》(以下簡稱“合夥協議”),公司作為有限合夥人參與上海譽道創業投資管理有限公司發起、會同其他合作方共同投資設立嘉興御道數科股權投資合夥企業(有限合夥),公司本次擬以自有資金認繳出資1,545.00萬元,出資比例為59.9767%。
合夥企業僅股權投資於:是石科技(平湖)有限公司,投資金額為人民幣2,576.00萬元,基金投資款用於該公司持續研發投入、拓展銷售團隊、補充流動資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.